Mr Charles Wang Chong Guang
Non-Executive Chairman
The business, the people and the ownership behind AsiaMedic.
Business overview
AsiaMedic is an integrated healthcare provider in Singapore. Its services span diagnostic imaging, health screening and primary healthcare, including medical wellness and screening services delivered through its facilities.
Listed security
Board & management
Non-Executive Chairman
Non-Executive Director
Independent Director
Independent Director
Independent Director
Chief Executive Officer (“CEO”)
Roles listed in ASIAMEDIC LIMITED ANNUAL REPORT 2025; current appointments are not independently verified.
Holdings
Direct interest: 358,471,030 shares, 31.74%; deemed interest: – shares, –
As shown in the Register of Substantial Shareholders; as at 19 March 2026Direct interest: – shares, –; deemed interest: 358,471,030 shares, 31.74%
As shown in the Register of Substantial Shareholders; as at 19 March 2026Direct interest: – shares, –; deemed interest: 358,471,030 shares, 31.74%
As shown in the Register of Substantial Shareholders; as at 19 March 2026Direct interest: 76,813,516 shares, 6.80%; deemed interest: – shares, –
As shown in the Register of Substantial Shareholders; as at 19 March 2026Direct interest: – shares, –; deemed interest: 76,813,516 shares, 6.80%
As shown in the Register of Substantial Shareholders; as at 19 March 2026Direct interest: – shares, –; deemed interest: 76,813,516 shares, 6.80%
As shown in the Register of Substantial Shareholders; as at 19 March 2026Direct interest: 76,813,516 shares, 6.80%; deemed interest: – shares, –
As shown in the Register of Substantial Shareholders; as at 19 March 2026Direct interest: – shares, –; deemed interest: 76,813,516 shares, 6.80%
As shown in the Register of Substantial Shareholders; as at 19 March 2026Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-03-19 · PDF p. 97
| Registered holder | Interest | Shares / units | Source |
|---|---|---|---|
| INTEGRAL LEAD LIMITED | 358,471,030 shares; 31.74% | PDF p. 972026-03-19 | |
| CAPITAL BLAZE LIMITED | 76,813,516 shares; 6.80% | PDF p. 972026-03-19 | |
| DRAGON GLORIOUS LIMITED | 76,813,516 shares; 6.80% | PDF p. 972026-03-19 | |
| UNITED OVERSEAS BANK NOMINEES P L | 63,899,598 shares; 5.66% | PDF p. 972026-03-19 | |
| ANG HAO YAO (HONG HAOYAO) | 58,937,200 shares; 5.22% | PDF p. 972026-03-19 | |
| DBS NOMINEES PTE LTD | 45,528,900 shares; 4.03% | PDF p. 972026-03-19 | |
| PHILLIP SECURITIES PTE LTD | 17,401,300 shares; 1.54% | PDF p. 972026-03-19 | |
| UOB KAY HIAN PTE LTD | 13,238,000 shares; 1.17% | PDF p. 972026-03-19 | |
| MAYBANK SECURITIES PTE. LTD. | 12,960,800 shares; 1.15% | PDF p. 972026-03-19 | |
| OCBC SECURITIES PRIVATE LTD | 9,269,600 shares; 0.82% | PDF p. 972026-03-19 | |
| ANG KIM JOO MATTHEW | 8,268,400 shares; 0.73% | PDF p. 972026-03-19 | |
| LEE CHYE ONN @SOW CHYE ONN | 8,000,000 shares; 0.71% | PDF p. 972026-03-19 | |
| LISTIAWATI | 7,454,000 shares; 0.66% | PDF p. 972026-03-19 | |
| LOO TIONG KHENG | 6,099,900 shares; 0.54% | PDF p. 972026-03-19 | |
| OCBC NOMINEES SINGAPORE PTE LTD | 5,916,100 shares; 0.52% | PDF p. 972026-03-19 | |
| TOK BOON CHOO | 5,700,000 shares; 0.50% | PDF p. 972026-03-19 | |
| SSK INVESTMENTS O/S PTY LTD | 5,544,000 shares; 0.49% | PDF p. 972026-03-19 | |
| TAN KOK HENG | 5,000,000 shares; 0.44% | PDF p. 972026-03-19 | |
| RAFFLES NOMINEES(PTE) LIMITED | 4,981,700 shares; 0.44% | PDF p. 972026-03-19 | |
| DBS VICKERS SECURITIES (S) PTE LTD | 4,520,000 shares; 0.40% | PDF p. 972026-03-19 | |
Group structure
| Company | Market | Ownership interest |
|---|---|---|
| The Orchard Imaging Centre Pte. Ltd.Held by the Company; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore | 100 | |
| AsiaMedic Wellness Assessment Centre Pte. Ltd.Held by the Company; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore | 100 | |
| AsiaMedic PET/CT Centre Pte. Ltd.Held by the Company; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore | 100 | |
| Complete Healthcare International Pte. Ltd.Held by the Company; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore | 100 | |
| AMC Healthcare Pte. Ltd.Held by the Company; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore | 100 | |
| AsiaMedic Eye Centre Pte. Ltd.Held by the Company; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore | 100 | |
| AsiaMedic Astique The Aesthetic Clinic Pte. Ltd. [a]Held by AsiaMedic Wellness Assessment Centre Pte. Ltd.; Group's effective equity interest 2025 (2024: 100); incorporated in Singapore | – | |
| AsiaMedic Sunway Pte. Ltd.Held by AMC Healthcare Pte. Ltd.; Group's effective equity interest 2025 (2024: 50); incorporated in Singapore | 50 | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| MR ARIFIN KWEK ZHI BIN | Chief Executive Officer | PDF p. 11 | |
| MS YU HUI XUAN SYENNY | Chief Financial Officer | PDF p. 11 | |
| DR FIONA CHANG | Asst. Medical Director; Complete Healthcare International Pte Ltd | PDF p. 11 | |
| DR RAPHAEL YIIN | Consultant Radiologist | PDF p. 12 | |
| DR LOW KAH BOON | Consultant Radiologist | PDF p. 12 | |
| DR DAVID SIA | Consultant Radiologist | PDF p. 12 |
Extracted from ASIAMEDIC LIMITED ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Purchase of consumables from associate | 421,800 $ | Group, 2025 (2024: 422,275) | PDF p. 88 |
| Key management personnel compensation total | 751,595 $ | Group, 2025 (2024: 741,354) | PDF p. 89 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Security granted | The Company provided a corporate guarantee for the term loan. | Company · As at 2025-12-31 | PDF p. 87 |
| Deficiencies in shareholders’ funds | 16,929,997 $ | Company, 2025 (2024: 18,506,941) · As at 2025-12-31 | PDF p. 90 |
| Current liabilities in excess of current assets | 17,118,895 $ | Company, 2025 (2024: 22,052,817) · As at 2025-12-31 | PDF p. 90 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Directors and CEO remuneration total | $173,000 | FY2025 total directors' fees | PDF p. 31 |
| Charles Wang | $42,000 | FY2025 | PDF p. 31 |
| Aona Liu | $27,000 | FY2025 | PDF p. 31 |
| Alice Ng | $37,000 | FY2025 | PDF p. 31 |
| Chua Keng Woon | $35,000 | FY2025 | PDF p. 31 |
| Leong Yew Meng | $32,000 | FY2025 | PDF p. 31 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Salaries and bonuses to employees | 12,481,456 $ | Group, 2025 (2024: 11,265,752) | PDF p. 83 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| OUTLOOK | Looking ahead, the Group will continue to focus on strengthening its core capabilities in diagnostic imaging and preventive healthcare. | Chairman's Statement | PDF p. 14 |
Extracted from ASIAMEDIC LIMITED ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.
Corporate information